Home/Filings/4/0001209191-20-019584
4//SEC Filing

Levy Howard 4

Accession 0001209191-20-019584

CIK 0001124105other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:23 PM ET

Size

5.3 KB

Accession

0001209191-20-019584

Insider Transaction Report

Form 4
Period: 2020-03-16
Levy Howard
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-03-16$4.05/sh+2,500$10,1322,500 total
Holdings
  • Common Stock

    (indirect: By Trust)
    17,452

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001672333

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:23 PM ET
Size
5.3 KB